UNSPSC 85874414: Ultrasonography of left lower extremity veins, guidance

This classification denotes the group of activities that yields a imaging intervention or procedure to ultrasonography of left lower extremity veins, guidanceultrasonography of left lower extremity veins, guidance. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B54CZZA

UNSPSC 85874414 Ultrasonography of left lower extremity veins, guidance is a Commodity code with minimal directly aligned recent state and local procurement activity. The three most recent opportunities posted under or near this code—a diagnostic imaging PACS system procurement by San Mateo Medical Center, special education contracted services by Birdville Independent School District, and a temporary health professional staffing pool by Santa Clara County Health System—show misalignment with the code's nominal scope of ultrasound guidance for lower-extremity venous imaging. The San Mateo opportunity addresses enterprise radiology and cardiology imaging infrastructure rather than point-of-care ultrasound services; the Birdville solicitation concerns school-based special education contractors unrelated to vascular imaging; and Santa Clara's staffing pool includes diagnostic imaging and audiology among multiple categories but does not specify ultrasound-guided procedures. State and local procurement activity under this specific commodity code appears sparse or mislabeled in available recent postings.

Geographic activity is scattered across California (San Mateo and Santa Clara counties) and Texas (Tarrant County), with no concentration signal in the recent record. The issuing bodies span a county health system, a public hospital and clinic operator, and an independent school district—a mix indicating no systematic purchasing pattern. Without representative opportunities genuinely aligned to ultrasound-guided lower-extremity venous imaging, the code presents no clear market signal for business development focus at this time.